PGP Investors

In early 2007, PGP Corporation raised $27.3 million in Series C funding. Intel Capital, the venture capital arm of Intel Corporation, and the D. E. Shaw group, a global investment and technology development firm, joined existing investors DCM (formerly known as DCM-Doll Capital Management) and Venrock Associates, providing funds to enable PGP Corporation to accelerate technology development and channel expansion. The funding enables the company to extend the flagship PGP® Encryption Platform with key management functionality that allows customers to transparently manage third-party devices and software from PGP Corporation, independent software vendors, and customer in-house applications.

In August 2002, PGP Corporation received $14 million in venture funding from DCM and Venrock Associates. In December 2005, PGP Corporation received $10 million in growth capital funding from DCM and Venrock Associates. Funds went toward accelerating R&D efforts and expansion of the PGP Encryption Platform.

DCM

DCM is an early stage venture capital firm supporting entrepreneurs that build world-class technology companies. The firm's partners manage $1.6 billion and have funded leading technology companies including: 2Wire, 51job, @Motion (Openwave), About.com (The New York Times Co.), All About , Arroyo (Cisco), Clearwire, Dang Dang, eDreams (TA), Foundry Networks, HireRight, Internap, IPivot (Intel), JCI, Neopath Networks (Cisco), Neutral Tandem, nQuire (Siebel), PGP Corporation, Recourse Technologies (Symantec), Sigmatel, SMIC, Sling Media (EchoStar), VanceInfo and Vimicro. DCM offers hands-on operational guidance and access to an extensive network of resources, including close relationships with many of the Pacific Rim's leading companies and investors. For more information, please visit the DCM website at www.dcm.com.

D. E. Shaw Group

The D. E. Shaw group is a global investment and technology development firm with more than 1,400 employees and approximately $39 billion in aggregate investment capital. The firm has offices in North America, Europe, and Asia. Since 1988, the firm has earned an international reputation for financial innovation, technological leadership, and an extraordinarily distinguished staff. For more information, please visit the D. E. Shaw group website at www.deshaw.com.

Intel Capital

Among the largest venture capital entities in the world, Intel Capital seeks out and invests in promising technology companies worldwide, focusing on both established and new technologies that help to develop industry standard solutions, drive global Internet growth, facilitate new usage models, and advance the computing and communications platforms. Since 1991, Intel Capital has invested more than $7.5 billion in approximately 1,000 companies in 45 countries. Among its investments are: Actions Semiconductor, Bellrock Media, Broadcom, CNET, CitrixSystems, Clearwire, Elpida Memory, FPT, India Infoline.com, Inktomi, Insyde Software, Integrant Technologies, Marvell, MySQL, NIIT, PCCW, Red Hat, Rediff.com, Research in Motion, Sasken, SiRF, Smart Technologies, Sohu.com, Techfaith, VA Linux, and WebMD. For more information, please visit the Intel Capital website at www.intel.com/capital.

Venrock Associates

Venrock Associates is a premier venture capital firm with offices in Menlo Park; New York; Cambridge, Massachusetts; and Israel. Originally established as the venture capital arm of the Rockefeller family, Venrock continues a seven-decade tradition of partnering with entrepreneurs to establish successful, enduring companies. Having invested $2.2 billion in 417 companies resulting in 124 IPOs and 117 merger and acquisition exits over the past 39 years, Venrock investment returns place it among the top-tier venture capital firms that have achieved consistently superior performance. With a primary focus on technology, healthcare, and energy, Venrock portfolio companies have included: Apple Computer, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec Pharmaceuticals, Illumina, Intel, Millennium Pharmaceuticals, Sirna Therapeutics, and StrataCom. For more information, please visit the Venrock website at www.venrock.com.